First Time Loading...

United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 271.835 USD -0.31%
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Cash Flow Statement

979.7m
+0.2%
Operating Cash Flow
Growth Rates:
1 Year
+10%
3 Years
+55%
5 Years
-
7 Years
+31%
10 Years
+124%
236.8m
Investing Cash Flow
Growth Rates:
1 Year
-
3 Years
-
5 Years
-
7 Years
-
10 Years
-
-1.1B
-9 383%
Financing Cash Flow
Growth Rates:
1 Year
-
3 Years
-
5 Years
-
7 Years
-232%
10 Years
-1 187%

Cash Flow Statement
United Therapeutics Corp

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Operating Cash Flow
Net Income
250
282
194
340
186
173
663
652
904
1 011
708
714
657
395
509
418
484
713
543
589
(150)
(118)
(92)
(105)
528
430
469
515
405
471
462
476
687
631
707
727
728
872
900
985
1 051
Depreciation & Amortization
31
31
31
32
33
34
34
33
32
32
32
32
32
32
31
31
31
31
33
36
38
41
44
46
48
50
49
50
50
50
50
50
50
50
51
51
52
52
53
53
55
Change in Deffered Taxes
152
174
125
185
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
225
190
336
190
485
534
195
280
(99)
(145)
24
12
138
134
60
74
(9)
14
89
(26)
104
46
19
45
47
136
100
164
173
150
188
139
77
114
87
107
116
64
87
39
77
Other Non-Cash Items
233
190
332
183
471
510
(179)
(100)
(474)
(505)
18
16
136
386
317
104
30
(205)
(115)
29
166
75
49
33
11
143
104
131
188
164
217
247
145
220
177
165
190
91
97
38
60
Cash Taxes Paid
164
197
200
196
145
165
135
293
366
405
460
362
274
298
329
347
347
221
148
103
103
134
145
120
111
102
88
93
100
134
161
153
155
206
212
276
275
285
323
333
337
Cash Interest Paid
6
5
5
6
4
4
2
1
0
0
0
2
2
3
5
8
9
10
11
9
16
26
34
41
39
33
26
21
17
16
16
16
16
18
22
29
38
47
53
56
56
Change in Working Capital
(226)
(377)
(312)
(386)
(446)
(316)
(128)
(202)
(62)
(53)
(252)
(117)
(76)
(119)
(134)
(78)
(26)
89
146
124
(179)
(170)
(224)
(181)
49
43
111
60
(12)
(70)
(180)
(174)
(85)
(126)
(87)
(141)
(82)
(147)
(94)
(98)
(185)
Cash from Operating Activities
438
N/A
300
-32%
369
+23%
355
-4%
354
0%
449
+27%
448
0%
383
-15%
400
+4%
484
+21%
506
+4%
644
+27%
749
+16%
694
-7%
723
+4%
474
-34%
519
+9%
628
+21%
607
-3%
778
+28%
(125)
N/A
(172)
-38%
(224)
-30%
(207)
+8%
635
N/A
667
+5%
732
+10%
756
+3%
631
-17%
615
-3%
550
-11%
598
+9%
797
+33%
776
-3%
849
+9%
803
-5%
889
+11%
868
-2%
956
+10%
978
+2%
980
+0%
Investing Cash Flow
Capital Expenditures
(46)
(54)
(59)
(47)
(33)
(24)
(21)
(50)
(55)
(61)
(60)
(43)
(50)
(60)
(73)
(86)
(108)
(141)
(160)
(184)
(172)
(139)
(111)
(84)
(72)
(70)
(72)
(59)
(57)
(55)
(63)
(121)
(124)
(124)
(170)
(139)
(167)
(194)
(191)
(230)
(227)
Other Items
(153)
(89)
189
386
333
273
520
553
502
485
156
92
(80)
(268)
(476)
(749)
(620)
(756)
(866)
(636)
(650)
(366)
(363)
(252)
(231)
(566)
(537)
(679)
(660)
(336)
(292)
(366)
(716)
(836)
(648)
(673)
(507)
(537)
(760)
(489)
464
Cash from Investing Activities
(199)
N/A
(144)
+28%
130
N/A
339
+160%
301
-11%
249
-17%
499
+100%
504
+1%
447
-11%
424
-5%
96
-77%
48
-50%
(129)
N/A
(328)
-154%
(549)
-67%
(836)
-52%
(729)
+13%
(897)
-23%
(1 027)
-14%
(821)
+20%
(822)
0%
(505)
+39%
(474)
+6%
(335)
+29%
(303)
+10%
(636)
-110%
(609)
+4%
(739)
-21%
(717)
+3%
(391)
+46%
(355)
+9%
(487)
-37%
(840)
-72%
(960)
-14%
(818)
+15%
(812)
+1%
(673)
+17%
(732)
-9%
(951)
-30%
(720)
+24%
237
N/A
Financing Cash Flow
Net Issuance of Common Stock
(100)
(336)
(354)
(430)
(482)
(386)
(427)
(351)
(329)
(293)
(379)
(488)
(335)
(447)
(311)
(206)
(230)
22
21
20
19
15
14
14
6
27
31
39
56
45
56
56
43
56
47
94
152
152
153
105
(914)
Net Issuance of Debt
0
74
(1)
(178)
(192)
(357)
(285)
(133)
(119)
(37)
(35)
(9)
(9)
249
250
250
0
0
0
0
800
800
750
600
(250)
(250)
(200)
(50)
0
0
0
0
0
0
0
0
0
0
0
(100)
(200)
Other
14
21
27
31
34
40
39
37
24
11
4
(1)
3
2
1
(1)
(1)
(13)
(13)
(13)
(14)
(3)
(3)
(3)
(4)
(4)
(4)
(5)
(12)
(12)
(12)
(11)
(19)
(19)
(19)
(19)
(17)
(17)
(16)
(17)
(14)
Cash from Financing Activities
(88)
N/A
(241)
-175%
(328)
-36%
(577)
-76%
(640)
-11%
(703)
-10%
(672)
+4%
(447)
+34%
(425)
+5%
(319)
+25%
(410)
-28%
(498)
-21%
(340)
+32%
(196)
+42%
(60)
+69%
43
N/A
20
-55%
9
-53%
8
-12%
6
-21%
805
+12 675%
812
+1%
761
-6%
611
-20%
(248)
N/A
(227)
+9%
(173)
+24%
(17)
+90%
43
N/A
32
-25%
43
+34%
45
+3%
24
-47%
37
+56%
27
-26%
75
+175%
135
+79%
136
+1%
136
+0%
(12)
N/A
(1 129)
-9 383%
Change in Cash
Effect of Foreign Exchange Rates
0
1
(1)
(4)
(7)
(6)
(7)
(5)
(2)
(6)
(4)
(3)
(3)
(1)
0
0
0
(0)
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Change in Cash
152
N/A
(84)
N/A
170
N/A
114
-33%
8
-93%
(10)
N/A
268
N/A
434
+62%
420
-3%
583
+39%
188
-68%
191
+2%
276
+44%
168
-39%
115
-32%
(318)
N/A
(190)
+40%
(260)
-37%
(412)
-58%
(36)
+91%
(142)
-296%
135
N/A
64
-53%
69
+9%
85
+22%
(196)
N/A
(50)
+75%
0
N/A
(43)
N/A
257
N/A
238
-7%
156
-34%
(19)
N/A
(147)
-674%
58
N/A
66
+14%
350
+427%
272
-22%
141
-48%
247
+75%
88
-64%
Free Cash Flow
Free Cash Flow
392
N/A
246
-37%
311
+26%
308
-1%
321
+4%
425
+33%
427
+0%
333
-22%
345
+4%
423
+23%
446
+5%
600
+35%
699
+16%
633
-9%
650
+3%
388
-40%
411
+6%
487
+19%
447
-8%
594
+33%
(297)
N/A
(310)
-5%
(335)
-8%
(290)
+13%
564
N/A
597
+6%
660
+11%
696
+5%
574
-18%
560
-2%
487
-13%
477
-2%
673
+41%
652
-3%
679
+4%
664
-2%
722
+9%
674
-7%
764
+13%
748
-2%
752
+1%

See Also

Summary
UTHR intrinsic value, competitors valuation, and company profile.
DCF Valuation
UTHR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
UTHR stock valuation using valuation multiples.
Wall Street Estimates
UTHR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
UTHR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.